Mainstream

Shell misses top-line and bottom-line estimates; initiates Q2 outlook

Shell misses top-line and bottom-line estimates; initiates Q2 outlook

Post Contentshel, rydafRead More

You might also be interested in reading Novartis succeeds in late-stage Sjögren’s disease trials.

May 2, 2025
In Mainstream